Federal Policy
Latham & Watkins Drug Pricing Digest Compiles August 2026 Regulatory Updates
Latham & Watkins published its Drug Pricing Digest for August 2026, tracking recent developments across the Medicaid Drug Rebate Program, 340B Program, Medicare, and state law. The digest compiles regulatory updates, guidance, and legal developments affecting pharmaceutical pricing and market access across federal and state programs. This ongoing tracker serves as a reference for manufacturers, health plans, and providers navigating drug pricing compliance and reimbursement. The publication does not report a single new regulatory action but consolidates recent activity in pharmaceutical policy.
Why it mattersMedicaid managed care organizations and state agencies rely on understanding Medicaid Drug Rebate Program changes and 340B developments to manage pharmacy benefits, capitation rate negotiations, and contract pharmacy arrangements.